Maya Biotech Private Limited

Ceftazidime and Tazobactam dry injection is a potent antibiotic combination used to treat a wide range of bacterial infections. Ceftazidime acts by inhibiting the bacterial cell wall synthesis, leading to bacterial death. Tazobactam, a beta-lactamase inhibitor, enhances the effectiveness of Ceftazidime by preventing bacterial resistance. This injectable formulation is effective against severe infections including respiratory, urinary tract, skin, and intra-abdominal infections, and is administered under medical supervision.

Ceftazidime Injection IP is a powerful broad-spectrum cephalosporin antibiotic used to treat serious bacterial infections such as pneumonia, meningitis, urinary tract infections, skin infections, and bone and joint infections. It works by inhibiting bacterial cell wall synthesis, leading to bacterial death. Administered intravenously or intramuscularly, it is effective against resistant bacteria including Pseudomonas aeruginosa. The medication requires medical supervision for proper dosing and is essential for treating infections caused by susceptible bacteria.